Patents by Inventor Michael Christie

Michael Christie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240067560
    Abstract: An aqueous treating medium may include water; an acid selected from the group consisting of: HCl, HBr, HNO3, H2SO4, H2SO3, H3PO4, H3PO2, HOAc, citric acid, tartaric acid, ascorbic acid, EDTA, methanesulfonic acid, toluenesulfonic acid, and combinations thereof, wherein a concentration of the acid in the aqueous treating medium is from 0.5 M to 1.5 M; a salt, wherein a concentration of the salt in the aqueous treating medium is from greater than 0 M to 2 M; a fluoride-containing compound selected from the group consisting of: HF, NaF, NH4HF2, and combinations thereof, wherein a concentration of the fluoride-containing compound in the aqueous treating medium is from 0.026 M to 0.26 M; and silica, wherein the aqueous treating medium is saturated with silica.
    Type: Application
    Filed: August 24, 2023
    Publication date: February 29, 2024
    Inventors: Gabriel Pierce Agnello, Dane Alphanso Christie, Richard Michael Fiacco, Eric Emil Leonhardt, Adam Robert Sarafian, Bryan Henry Smith
  • Publication number: 20230339967
    Abstract: This application relates to solid forms of an S1P-receptor modulator, which are useful in the treatment of diseases or disorders associated with activity of S1P, including CNS disorders.
    Type: Application
    Filed: November 22, 2022
    Publication date: October 26, 2023
    Inventors: Stéphane De Lombaert, Ana Rosario Mollo Sarno, Michael A. Christie, Edward L. Ciolkowski, Susana del Rio Gancedo, Joseph Stephen Harris, Lucy Kristina Mapp, Mateusz Bogumil Pitak, Scott L. Childs
  • Publication number: 20230305182
    Abstract: The disclosure presents processes to locate one or more quantum gravimeters at a hydrocarbon well site, with at least one quantum gravimeter at a surface location. Zero or more additional gravimeters, whether quantum gravimeters or non-quantum gravimeters, can be located downhole a wellbore of the well site. Gravitational data collected from various gravimeters can be analyzed to produce analyzed gravitational parameters and subterranean formation parameters. In some aspects, the gravitational data can be processed, such as by an inversion algorithm or a noise reduction algorithm. The generated results can be used to calibrate non-quantum gravimeters located proximate the well site or downhole the wellbore, identify a depth and direction of a water front, identify the fluid flow of hydrocarbons or water in the subterranean formation, to identify orphaned hydrocarbon reservoirs, or other characteristics of fluid flow or subterranean formation parameters, such as subterranean formation damage.
    Type: Application
    Filed: March 25, 2022
    Publication date: September 28, 2023
    Inventors: Michael Linley Fripp, Michael Christie, Luke William Holderman, Arpana Singh
  • Patent number: 11535632
    Abstract: This application relates to solid forms of an S1P-receptor modulator, which are useful in the treatment of diseases or disorders associated with activity of S1P, including CNS disorders.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: December 27, 2022
    Assignee: ESCAPE Bio, Inc.
    Inventors: Stéphane De Lombaert, Ana Rosario Mool Sarno, Michael A. Christie, Edward L. Ciolkowski, Susana del Rio Gancedo, Joseph Stephen Harris, Lucy Kristina Mapp, Mateusz Bogumil Pitak, Scott L. Childs
  • Publication number: 20210139503
    Abstract: This application relates to processes for preparing an S1P-receptor modulator, which is useful in the treatment of diseases or disorders associated with activity of S1P, including CNS disorders.
    Type: Application
    Filed: October 30, 2020
    Publication date: May 13, 2021
    Inventors: Stéphane De Lombaert, Jonathon Daryll Schwarz Holt, Ana Rosario Mollo Sarno, Jacob Bradley Schwarz, Michael A. Christie, Edward L. Ciolkowski, Zenghong Zhang
  • Publication number: 20210139502
    Abstract: This application relates to solid forms of an S1P-receptor modulator, which are useful in the treatment of diseases or disorders associated with activity of S1P, including CNS disorders.
    Type: Application
    Filed: October 30, 2020
    Publication date: May 13, 2021
    Inventors: Stéphane De Lombaert, Ana Rosario Mollo Sarno, Michael A. Christie, Edward L. Ciolkowski, Susana del Rio Gancedo, Joseph Stephen Harris, Lucy Kristina Mapp, Mateusz Bogumil Pitak, Scott L. Childs
  • Patent number: 10100060
    Abstract: This invention is directed to asymmetric synthesis of funapide, which is useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: October 16, 2018
    Assignee: Xenon Pharmaceuticals Inc.
    Inventors: Ronen Ben-David, Jian Chen, Michael A. Christie, Mina Gadelrab Dimitri, Graciela Noemi Gershon, Linli He, Nelson G. Landmesser, Daniel V. Levy, Orel Yosef Mizrahi, Partha S. Mudipalli, Harlan F. Reese, Joseph A. Sclafani, Yi Wang
  • Publication number: 20180172707
    Abstract: A method for the diagnosis of Type 1 diabetes, or a predisposition towards Type 1 diabetes, or to monitor the efficacy of a therapy to prevent or treat Type 1 diabetes, said method comprising contacting a sample from a subject with a reagent selected from Tetraspanin-7 or a fragment, or a modified form thereof, and detecting an interaction indicative of the presence of an autoimmune response to Tetraspanin-7. Tetraspanin-7 is now understood to be the protein recognised by Glima 38 specific antibodies. Reagents and kits for use in the method and therapies associated with these form further aspects of the invention.
    Type: Application
    Filed: June 1, 2016
    Publication date: June 21, 2018
    Inventors: Michael CHRISTIE, Kerry MCLAUGHLIN, Carolyn JOHNSON, Aarthi RAVISHANKAR
  • Publication number: 20180002341
    Abstract: This invention is directed to asymmetric synthesis of funapide, which is useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
    Type: Application
    Filed: June 16, 2017
    Publication date: January 4, 2018
    Inventors: Ronen Ben-David, Jian Chen, Michael A. Christie, Mina Gadelrab Dimitri, Graciela Noemi Gershon, Linli He, Nelson G. Landmesser, Daniel V. Levy, Orel Yosef Mizrahi, Partha S. Mudipalli, Harlan F. Reese, Joseph A. Sclafani, Yi Wang
  • Publication number: 20150011759
    Abstract: The present invention provides a short, safe, inexpensive, commercially scalable process for preparing (R)- or (S)-2-methylpyrrolidine from 2-methylpyrroline, which does not require the isolation of synthetic intermediates.
    Type: Application
    Filed: July 25, 2014
    Publication date: January 8, 2015
    Applicant: CEPHALON, INC.
    Inventors: Michael Christie, Joseph J Petraitis
  • Patent number: 8730971
    Abstract: A method of operating a communication signaling processor is disclosed. The method comprises receiving a signaling message for a voice call to a called party, processing the signaling message to transfer a query to a database that is updated when the called party changes locations, receiving a response from the database, and processing the response to select an identifier for a header of a voice communication to route the voice call to the called party.
    Type: Grant
    Filed: December 5, 2007
    Date of Patent: May 20, 2014
    Assignee: Sprint Communications Company L.P.
    Inventor: Joseph Michael Christie
  • Patent number: 8633314
    Abstract: The present invention provides alternative forms of Compound I, processes to reproducibly make them and methods of treating patients using them.
    Type: Grant
    Filed: February 24, 2012
    Date of Patent: January 21, 2014
    Assignee: Cephalon, Inc.
    Inventors: Stephen Bierlmaier, Michael Christie, R. Scott Field, R. Curtis Haltiwanger, Linli He, Martin J. Jacobs, Michael Kress, Robert E. McKean, Dale R. Mowrey, Joseph Petraitis, Mehran Yazdanian, Veronique Courvoisier
  • Publication number: 20120214998
    Abstract: The present invention provides alternative forms of Compound I, processes to reproducibly make them and methods of treating patients using them.
    Type: Application
    Filed: February 24, 2012
    Publication date: August 23, 2012
    Applicant: Cephalon, Inc.
    Inventors: Stephen Bierlmaier, Michael Christie, Laurent Courvoisier, Veronique Courvoisier, R. Scott Field, R. Curtis Haltiwanger, Linli He, Martin J. Jacobs, Michael Kress, Robert E. McKean, Dale R. Mowrey, Joseph Petraitis, Mehran Yazdanian
  • Patent number: 7894422
    Abstract: A communication processing system handles a plurality of calls. On a call-by-call basis for each of the calls, the system receives a control message indicating a route identifier for the call, receives a voice band communication for the call, and determines if the voice band communication should be compressed. If the voice band communication should be compressed, the system compresses the voice band communication, adds the route identifier from the control message to the compressed voice band communication, and transfers the compressed voice band communication with the route identifier. If the voice band communication should be not compressed, the system adds the route identifier from the control message to the voice band communication and transfers the voice band communication with the route identifier.
    Type: Grant
    Filed: February 7, 2008
    Date of Patent: February 22, 2011
    Assignee: Sprint Communications Company L.P.
    Inventors: Albert Daniel DuRee, Joseph Michael Christie, Joseph S. Christie, legal representative, Jean M. Christie, legal representative, Mark Sucharczuk
  • Publication number: 20100121055
    Abstract: The present invention provides a short, safe, inexpensive, commercially scalable process for preparing (R)- or (S)-2-methylpyrrolidine from 2-methylpyrroline, which does not require the isolation of synthetic intermediates.
    Type: Application
    Filed: November 3, 2009
    Publication date: May 13, 2010
    Applicant: CEPHALON, INC.
    Inventors: Michael Christie, Joseph J. Petraitis
  • Patent number: 7505454
    Abstract: The present invention includes a method, system, and apparatus for providing communication control. The invention includes a method in which signaling is processed externally to a switch before it is applied by the network elements. The processor is able to select network characteristics and signal the network elements based the selections. A network employing the processing method is also included, as well as a signaling system that employs the processing method.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: March 17, 2009
    Assignee: Sprint Communications Company L.P.
    Inventor: Joseph Michael Christie
  • Patent number: 7471698
    Abstract: The present invention is an apparatus, system, and method for converting point codes in a signal transfer point in a telecommunications signaling system. The STP converts point codes which designate the origination and destination signaling points for the message. The conversion is based on information defined by the messages, such as origination or destination information. The present invention creates a virtual signaling system which can be reconfigured at the STP by converting point codes, and thus, altering the identities of the signaling points. The present invention is also operable to convert circuit identification codes and transfer integrated services user part messages to a user part.
    Type: Grant
    Filed: April 8, 2003
    Date of Patent: December 30, 2008
    Assignee: Sprint Communications Company L.P.
    Inventors: Joseph Michael Christie, Albert Daniel Duree, Michael Joseph Gardner, William Lyle Wiley
  • Patent number: 7394894
    Abstract: A signaling processor receives a first signaling message indicating a called telephone number for the call. The signaling processor processes the called telephone number from the first signaling message to determine if call validation is required. If the call validation is not required, then the signaling processor processes the called telephone number to determine routing information without the call validation. If the call validation is required, then the signaling processor determines if the call is valid, and if the call is valid, then the signaling processor processes the called telephone number to determine the routing information. The signaling processor transfers a second signaling message indicating the routing information for the call.
    Type: Grant
    Filed: May 16, 2006
    Date of Patent: July 1, 2008
    Assignee: Sprint Communications Company L.P.
    Inventors: Joseph Michael Christie, Manu Chand Bahl, Albert Daniel Duree, Michael Joseph Gardner, Daniel Charles Sbisa, William Lyle Wiley
  • Publication number: 20080130864
    Abstract: A communication processing system handles a plurality of calls. On a call-by-call basis for each of the calls, the system receives a control message indicating a route identifier for the call, receives a voice band communication for the call, and determines if the voice band communication should be compressed. If the voice band communication should be compressed, the system compresses the voice band communication, adds the route identifier from the control message to the compressed voice band communication, and transfers the compressed voice band communication with the route identifier. If the voice band communication should be not compressed, the system adds the route identifier from the control message to the voice band communication and transfers the voice band communication with the route identifier.
    Type: Application
    Filed: February 7, 2008
    Publication date: June 5, 2008
    Applicant: Sprint Communications Company L.P.
    Inventors: Albert Daniel Duree, Joseph Michael Christie, Joseph S. Christie, Jean M. Christie, Mark Sucharczuk
  • Patent number: 7376131
    Abstract: A communication system receives a signaling message for a voice communication and processes the signaling message to select a route identifier. The system selects a processing technique for the voice communication, such as compression or encryption. The system processes the voice communication with the selected processing technique. The system adds the selected route identifier to the voice communication. The system adds a processing indicator to the voice communication. The system transfers the voice communication with the route identifier and the processing indicator.
    Type: Grant
    Filed: February 26, 2007
    Date of Patent: May 20, 2008
    Assignee: Sprint Communications Company L.P.
    Inventors: Albert Daniel DuRee, Joseph S. Christie, legal representative, Jean M. Christie, legal representative, Mark Sucharczuk, Joseph Michael Christie